#oral-glp1

For the first time ever, consumers can choose between two FDA-approved GLP-1 pills for weight loss. Foundayo (orforglipron) and oral Wegovy (semaglutide) take fundamentally different approaches — here's how they compare on efficacy, dosing convenience, side effects, and price.

Beyond Wegovy and Zepbound, a new generation of obesity drugs is racing toward FDA approval. CagriSema, MariTide (monthly injection), survodutide, and more — here's every drug in the pipeline with clinical data.

The FDA just approved Eli Lilly's Foundayo (orforglipron) — the only GLP-1 weight loss pill with no food, water, or timing restrictions. Here's what it costs, how it works, and how it compares to Wegovy and Zepbound.